Seasonal flu epidemic in the Netherlands The flu epidemic in the Netherlands has started. The number of people with flu (influenza) increased significantly in the past two weeks.
Protection from COVID-19 booster wanes slightly after 3 months among over-70s In the period from 1 February to 8 March 2022, the first indications were observed that protection against hospital admission after COVID-19 booster vaccination decreases over time in people over 7
Hardly any decrease in overweight, smoking and alcohol use since 2018 In 2021 half of all adults were overweight. 21% sometimes smoked, 7% were excessive drinkers and 8% heavy drinkers.
Novavax vaccine available The Novavax vaccine is a protein-based vaccine which can offer an alternative for people who are hesitant about immunisation with an mRNA vaccine or vector vaccine, or for people who have a contraindication for mRNA vaccines.
Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
People aged 70 and up invited for repeat vaccination against COVID-19 People aged 70 years and older living in the Netherlands may receive an invitation for a repeat booster against COVID-19 from 26 February 2022 on. They can make an appointment for vaccination by the Municipal Public Health Services (GGDs).
Booster vaccination prevents many hospital and ICU admissions In the period from 26 January to 8 February 2022, the COVID-19 vaccines were 92% effective in preventing hospital admission after the booster, and 55% effective after the basic vaccinations.
Weekly vaccination figures per neighbourhood available through open data As of today, RIVM will publish weekly updates on vaccination turnout and vaccination coverage per neighbourhood in the Netherlands, both cumulative and broken down by calendar week.
Boosters improve diminished protection against Omicron infection after basic COVID-19 vaccination or previous infection Vaccination or previous infection with the coronavirus SARS-CoV-2 provide less effective protection against the Omicron variant compared to the Delta variant. A COVID-19 booster vaccination ensures renewed protection against Omicron.
Use of e-health increases but not always effective 2021 saw an increase in the use of e-health in every part of the healthcare industry in comparison with 2019. There were several reasons for this, including the coronavirus pandemic.